Skip to main content
Apeloa Pharmaceutical Co.,Ltd. logo

Apeloa Pharmaceutical Co.,Ltd. — Investor Relations & Filings

Ticker · 000739 ISIN · CNE000000Q45 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,843 across all filing types
Latest filing 2020-07-01 Earnings Release
Country CN China
Listing Shenzhen Stock Exchange 000739

About Apeloa Pharmaceutical Co.,Ltd.

https://www.apeloa.com

Apeloa Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and distribution of active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms. The company operates three core business pillars: API production, Contract Development and Manufacturing Organization (CDMO) services, and finished drug products. Its therapeutic focus includes cardiovascular, anti-infective, anti-viral, and oncology treatments. Apeloa utilizes an integrated supply chain to deliver chemical and biological solutions to a global client base. The organization maintains compliance with international quality standards, including certifications from the FDA, EMA, and PMDA. Its CDMO services encompass the full product lifecycle, from process chemistry and analytical development to large-scale commercial manufacturing, supported by specialized technology platforms such as continuous flow chemistry and enzymatic synthesis.

Recent filings

Filing Released Lang Actions
2020年半年度业绩预告
Earnings Release Classification · 95% confidence The document is a performance forecast for the half-year period ending June 30, 2020, with estimated financial results and a disclaimer that the data is preliminary and unaudited. It explicitly states that detailed financial data will be disclosed in the company's 2020 half-year report. The document is short (713 characters) and serves as an earnings preview rather than a full financial report. This matches the definition of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. H1 2020
2020-07-01 Chinese
关于公司全资子公司购买的理财产品到期赎回的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company about the maturity and redemption of financial products purchased by its wholly-owned subsidiary. It details the amounts, dates, and returns of these investments. The document is relatively short (1435 characters) and focuses on a specific financial transaction update rather than a comprehensive financial report or earnings release. It does not contain full financial statements or detailed analysis, nor is it a regulatory certification or voting result. The content fits best with a Capital/Financing Update as it relates to the company's use of idle funds and investment products, their maturity, and redemption results.
2020-06-28 Chinese
关于第一期员工持股计划锁定期届满的提示性公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from 普洛药业股份有限公司 regarding the expiration of the lock-up period of its first employee stock ownership plan. It details the background of the plan, the shares involved, the lock-up period, and subsequent arrangements. The document is relatively short (1623 characters) and serves as a notification or update about the employee stock plan status rather than a detailed financial report or management discussion. It does not contain financial statements or detailed analysis but rather compliance and procedural information about the stock plan. This fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement about the employee stock ownership plan lock-up expiration and related compliance information, not a full report or financial supplement.
2020-06-10 Chinese
关于实际控制人名称变更的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding a change in the name of the company's actual controller. It explicitly states that the controlling entity's name has changed but the control relationship remains the same. There is no financial data, no mention of financial results, no meeting materials, no voting results, no legal proceedings, no capital changes, or other report types. The document is an announcement about a change in the controlling shareholder's name, which is a regulatory announcement but does not fit into categories like Major Shareholding Notification (MRQ) because it does not indicate a change in shareholding level, only a name change. Given the short length (413 characters) and the nature of the content, this fits best under Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2020-05-21 Chinese
关于控股子公司产品通过日本PMDA认证的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (502 characters) about a subsidiary's product passing certification by Japan's PMDA. It is an official company announcement regarding regulatory approval and market access, not a financial report or detailed filing. It does not contain financial data, management changes, voting results, or other report types. It is a regulatory announcement about product certification and market qualification, fitting best under Regulatory Filings (RNS).
2020-05-20 Chinese
关于全资子公司药品通过仿制药一致性评价的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by 普洛药业股份有限公司 regarding its wholly-owned subsidiary's drug passing a generic drug consistency evaluation, approved by the National Medical Products Administration (国家药品监督管理局). It details the drug's basic information, approval status, and potential impact on the company. The document is short (1049 characters) and serves as an official announcement of a regulatory approval event rather than a financial report or detailed management discussion. It does not contain financial statements, earnings data, or management changes. It is not a report publication announcement since it does not mention any report being published or attached. The content fits best under Regulatory Filings (RNS) as a general regulatory announcement about product approval and company impact.
2020-05-18 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.